Provention Bio, Inc.
PRVB · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$113,565 | -$114,432 | -$98,581 | -$43,285 |
| Dep. & Amort. | $1,228 | $387 | $33 | -$16 |
| Deferred Tax | $0 | $538 | $247 | $16 |
| Stock-Based Comp. | $19,028 | $11,839 | $13,223 | $2,842 |
| Change in WC | $17,937 | $6,320 | $8,717 | $4,394 |
| Other Non-Cash | -$36 | -$37 | $25 | -$16 |
| Operating Cash Flow | -$75,408 | -$95,385 | -$76,336 | -$36,065 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$795 | -$961 | -$1,111 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$103,082 | -$55,285 | -$28,715 | -$46,250 |
| Inv. Sales/Matur. | $30,750 | $25,150 | $55,000 | $0 |
| Other Inv. Act. | -$15,000 | $0 | $0 | $0 |
| Investing Cash Flow | -$88,127 | -$31,096 | $25,174 | -$46,250 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $104,639 | $102,329 | $113,139 | $62,941 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $129,384 | $102,377 | $114,291 | $62,941 |
| Financing Cash Flow | $129,384 | $102,377 | $114,291 | $62,941 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$34,151 | -$24,104 | $63,129 | -$19,374 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $78,190 | $102,294 | $39,165 | $58,539 |
| End Cash | $44,039 | $78,190 | $102,294 | $39,165 |
| Free Cash Flow | -$76,203 | -$96,346 | -$77,447 | -$36,065 |